This Securities Purchase Agreement (this “Agreement”) is dated as of May 19, 2014, by and between Axxess Pharma, Inc., a Nevada corporation (the “Company”), and Seaside 88, LP, a Florida limited partnership (such investor, including its successors and assigns, “Seaside”).
Address for Notice:
By: 2681 Eglinton Ave West Name: Toronto, Ontario M6M IT8 Title: Canada Attention: Daniel Bagi, M.D. Fax: Email: danielb@axxesspharmainc.com
With a copy (which shall not constitute notice) to: Szaferman Lakind Blumstein & Blader, PC 101 Grovers Mill Road Second Floor Lawrenceville, NJ 08648 Attention: Gregg E. Jaclin, Esq. Fax: 609-557-0964 Email: GJaclin@szaferman.com
Seaside 88, LP Address for Notice:
By: Seaside 88 Advisors, LLC 750 Ocean Royale Way Suite 1101 By: Juno Beach, FL 33408 Name: William J. Ritger Attention: William J. Ritger and Title: Manager Denis M. O’Donnell, M.D. Fax: 866-358-6721 Email: wjr@seaside88.com dod@seaside88.com
With a copy (which shall not constitute notice) to: White White & Van Etten PC 45 School Street Boston, MA 02108 Attention: David A. White, Esq. Fax: 617-225-0205 Email: daw@wwvlaw.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.